Emletra (Lopinavir/Ritonavir)

Emletra (Lopinavir/Ritonavir) – Antiretroviral for HIV Management

Emletra is a fixed-dose combination of Lopinavir and Ritonavir, classified under protease inhibitors, designed to manage HIV-1 infection in adults and children. This medication helps lower the viral load in the body and improve immune system function when taken in combination with other antiretroviral agents. Ritonavir boosts the effectiveness of Lopinavir by slowing its breakdown, ensuring sustained activity.

Uses of Emletra:

• Treatment of HIV-1 infection in combination with other antiretrovirals.

• Reduces risk of progression to AIDS-related complications.

• Helps improve CD4 cell counts in long-term therapy.

Dosage & Administration:

• Always take as directed by a healthcare provider.

• Usually taken twice daily with or without food.

• Dosage may vary based on age, weight, and other HIV medications in use.

Precautions:

• Not a cure for HIV; prevents replication only.

• Do not stop treatment without medical advice.

• Inform your doctor if pregnant, breastfeeding, or taking other medications.

• Regular blood tests are required to monitor liver function and viral response.